Discoveric Bio Group
Discoveric bio group is a biotechnology company focused on developing next-generation, multispecific antibody technologies for treating Alzheimer's Disease and Antimicrobial Resistance. They leverage their deep antibody development roots and expertise in AI to create fully human bi- and multi-specific antibodies. Their pipeline includes treatments for neurological diseases, infectious diseases, and potentially cancer and immune system diseases. The company is led by experienced pharma and biotech professionals with a track record of bringing projects from research to market.
Discoveric Bio Group
Discoveric bio group is a biotechnology company focused on developing next-generation, multispecific antibody technologies for treating Alzheimer's Disease and Antimicrobial Resistance. They leverage their deep antibody development roots and expertise in AI to create fully human bi- and multi-specific antibodies. Their pipeline includes treatments for neurological diseases, infectious diseases, and potentially cancer and immune system diseases. The company is led by experienced pharma and biotech professionals with a track record of bringing projects from research to market.